Sort by
Refine Your Search
-
the development of globally inclusive language technologies and to design transformative approaches to overcome them. Responsibilities of the post holders include the development of new methods for multilingual
-
A position exists, for a Research Assistant/Associate in the Department of Engineering, to work on a European consortium project, UP2030. UP2030 aims to support cities in driving the transitions
-
language technologies and to design transformative approaches to overcome them. The student will develop new methods for multilingual NLP that can be applied also to low resource languages. Research will
-
A position exists for a Research Assistant/Associate in High TRL Aerothermal Testing at the Department of Engineering. You will join the growing National Centre for Propulsion and Power team, based
-
Doctoral Partnership consortium (https://www.ahrc-cdp.org ). This project aims to explore wider stories and connections within the British Museum collection by conducting the first detailed technological
-
. This post will involve the use of cutting edge biochemical, proteomic, next generation sequencing and ribosome foot printing technologies. This position is available for an immediate appointment. Candidates
-
neuroscience, and digital technologies with the aim of improving mental health outcomes in both non-clinical and clinical populations. We are based at the MRC Cognition and Brain Sciences Unit, University of
-
investigate the evolution of developmental gene regulation in the grasses, especially as it relates to the evolution of development. The successful candidates will ideally have expertise in reverse and forward
-
with significant physical, psychological and economic burden on individuals, their families and society. Globally 15 million newborn infants are born preterm, and it is the largest cause of death in
-
. They are the commonest cause of cancer death in children and adults under 40 years old. There have been few new treatments for these patients making it imperative we optimise treatments we currently have. Much